-
Jan 14, 2022, 3:04 pm260 pts
MuggleheadPsychedelics firm Numinus Wellness Inc. is advancing its first proprietary psilocybin-based formulation to the clinical trial process. In a statement Friday, the company said it submitted a clinical trial application to Health Canada for its Phase 1 study, dubbed Hope, on a “naturally derived psilocybe…
Trending Today on NewsBudz
NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.
Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.
Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.
